“✍【텔레 GD684】 동종업계1위❤️ 학생작업대출 학생작대 주부작업대출❤️✍”的搜索结果，显示 161-170 项，共有 12396 项

1. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   1. Adults age 18 years or older. 2. Olmsted County residents at the time of study entry. Exclusion criteria: 1. Pediatric population (age<18). 2. Unwilling to ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Jacksonville, Fla., Rochester, Minn., Scottsdale/Phoenix, Ariz. The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide ...

5. 泌尿科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purposes of this study are to collect prostate surgical samples from metastatic patients to establish xenograft tumor lines for future ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the safety and feasibility of the spinal array in treatment of patients with leptomeningeal metastases within the ...

7. 重症监护科- 临床试验- 妙佑医疗国际

   The primary purpose of this study is to examine 1-year survival and rate of secondary infections in COVID-19 patients with and without acute kidney injury (AKI) ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... 1 prior systemic chemotherapy, immunotherapy, or chemoimmunotherapy. Two ... 1) or to primary colorectal carcinoma (Arm 2), based on treatment-related ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   In the study, 122 patients will be randomized in a 1:1 ratio to receive doxorubicin treatment (Arm 1) or L19TNF treatment in combination with doxorubicin (Arm 2) ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... (1) Cohort 1 focuses on cancers displaying a high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression ...